+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Non-Animal Alternative Testing Market By Technology, By Method, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2022
  • Region: Global
  • Allied Market Research
  • ID: 5671234
UP TO OFF until Nov 15th 2024
The global non-animal alternative testing market is envisioned to garner $29,390.3 million by 2030, growing from $9,806.6 million in 2021 at a CAGR of 13.48% from 2022 to 2030.

Animal testing has been common across generations to establish whether particular chemicals are safe for use by humans and/or the environment. However, this primary method raises a number of issues about the animals involved and is also widely seen as inhumane. This forced medical professionals and researchers everywhere to concentrate their efforts and adopt fresh approaches to understand disease pathophysiology in people. Recent experiments are guiding scientists toward non-animal testing and disease study techniques that are much more applicable to humans.

A large increase in the demand for pharmaceuticals and treatments among people as a result of increasing prevalence of various illnesses around the world is the primary reason driving expansion of the global non-animal alternative testing market. Additionally, increased focus of market players on the development of novel products such as artificial organs, to meet the rising demand for cutting-edge drug testing solutions for a variety of illnesses, such as diabetes, is anticipated to open doors for the market growth in the anticipated period. However, it is anticipated that throughout the projection period, lack of awareness among drug developers regarding the use and advantages of non-animal alternative testing is projected to restrain the market growth.

It has been demonstrated that the emergence of the COVID-19 pandemic had a positive impact on the development of the non-animal alternative testing industry. As the COVID-19 pandemic has had such a terrible impact on people's health and welfare globally, patients now take extra care and precautions to stay safe from viral infections. Due to the high rate of coronavirus transmission and prevalence of serious symptoms, many researchers have forbidden themselves from working in a wet laboratory and making any sort of contact with either humans or animals during pre-clinical testing of the drugs. As a result, the use of less invasive testing techniques has increased such as microarrays, which do not involve using animals.

The key players profiled in this report include VITROCELL Systems GmbH, Evotec SE, Biovit, MB Research Laboratories, Emulate, Inc., TARA Biosystems, Inc., Bio-Rad Laboratories, Inc., Abbott, Hurel Corporation, and TissUse GmbH.

KEY BENEFITS FOR STAKEHOLDERS

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the non-animal alternative testing market analysis from 2021 to 2030 to identify the prevailing non-animal alternative testing market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the non-animal alternative testing market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global non-animal alternative testing market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Technology

  • Cell Culture
  • High Throughput
  • Molecular Imaging
  • OMIC Technology

By Method

  • Cellular Assay
  • Biochemical Assay
  • In-silico
  • Ex-vivo

By End User

  • Pharmaceutical Industry
  • Cosmetics Household Products
  • Diagnostics
  • Chemicals Industry
  • Food Industry

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of LAMEA

Key Market Players

  • VITROCELL Systems GmbH
  • Evotec SE
  • Biovit
  • MB Research Laboratories
  • Emulate, Inc.
  • TARA Biosystems, Inc.
  • Bio-Rad Laboratories, Inc.
  • Abbott
  • Hurel Corporation
  • TissUse GmbH

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
3.7.Regulatory Guidelines
3.8.Value Chain Analysis
3.9.Market Share Analysis
3.10.Key Regulation Analysis
3.11.Patent Landscape
CHAPTER 4: NON-ANIMAL ALTERNATIVE TESTING MARKET, BY TECHNOLOGY
4.1 Overview
4.1.1 Market size and forecast
4.2 Cell Culture
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 High Throughput
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Molecular Imaging
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 OMIC Technology
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
CHAPTER 5: NON-ANIMAL ALTERNATIVE TESTING MARKET, BY METHOD
5.1 Overview
5.1.1 Market size and forecast
5.2 Cellular Assay
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Biochemical Assay
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 In-silico
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Ex-vivo
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
CHAPTER 6: NON-ANIMAL ALTERNATIVE TESTING MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Pharmaceutical Industry
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Cosmetics & Household Products
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Diagnostics
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Chemicals Industry
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country
6.6 Food Industry
6.6.1 Key market trends, growth factors and opportunities
6.6.2 Market size and forecast, by region
6.6.3 Market analysis by country
CHAPTER 7: NON-ANIMAL ALTERNATIVE TESTING MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Technology
7.2.3 North America Market size and forecast, by Method
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Technology
7.2.5.1.2 Market size and forecast, by Method
7.2.5.1.3 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Technology
7.2.5.2.2 Market size and forecast, by Method
7.2.5.2.3 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Technology
7.2.5.3.2 Market size and forecast, by Method
7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Technology
7.3.3 Europe Market size and forecast, by Method
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Technology
7.3.5.1.2 Market size and forecast, by Method
7.3.5.1.3 Market size and forecast, by End User
7.3.5.2 United Kingdom
7.3.5.2.1 Market size and forecast, by Technology
7.3.5.2.2 Market size and forecast, by Method
7.3.5.2.3 Market size and forecast, by End User
7.3.5.3 France
7.3.5.3.1 Market size and forecast, by Technology
7.3.5.3.2 Market size and forecast, by Method
7.3.5.3.3 Market size and forecast, by End User
7.3.5.4 Spain
7.3.5.4.1 Market size and forecast, by Technology
7.3.5.4.2 Market size and forecast, by Method
7.3.5.4.3 Market size and forecast, by End User
7.3.5.5 Italy
7.3.5.5.1 Market size and forecast, by Technology
7.3.5.5.2 Market size and forecast, by Method
7.3.5.5.3 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Technology
7.3.5.6.2 Market size and forecast, by Method
7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Technology
7.4.3 Asia-Pacific Market size and forecast, by Method
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 China
7.4.5.1.1 Market size and forecast, by Technology
7.4.5.1.2 Market size and forecast, by Method
7.4.5.1.3 Market size and forecast, by End User
7.4.5.2 Japan
7.4.5.2.1 Market size and forecast, by Technology
7.4.5.2.2 Market size and forecast, by Method
7.4.5.2.3 Market size and forecast, by End User
7.4.5.3 India
7.4.5.3.1 Market size and forecast, by Technology
7.4.5.3.2 Market size and forecast, by Method
7.4.5.3.3 Market size and forecast, by End User
7.4.5.4 South Korea
7.4.5.4.1 Market size and forecast, by Technology
7.4.5.4.2 Market size and forecast, by Method
7.4.5.4.3 Market size and forecast, by End User
7.4.5.5 Australia
7.4.5.5.1 Market size and forecast, by Technology
7.4.5.5.2 Market size and forecast, by Method
7.4.5.5.3 Market size and forecast, by End User
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Market size and forecast, by Technology
7.4.5.6.2 Market size and forecast, by Method
7.4.5.6.3 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Technology
7.5.3 LAMEA Market size and forecast, by Method
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Technology
7.5.5.1.2 Market size and forecast, by Method
7.5.5.1.3 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Technology
7.5.5.2.2 Market size and forecast, by Method
7.5.5.2.3 Market size and forecast, by End User
7.5.5.3 UAE
7.5.5.3.1 Market size and forecast, by Technology
7.5.5.3.2 Market size and forecast, by Method
7.5.5.3.3 Market size and forecast, by End User
7.5.5.4 South Africa
7.5.5.4.1 Market size and forecast, by Technology
7.5.5.4.2 Market size and forecast, by Method
7.5.5.4.3 Market size and forecast, by End User
7.5.5.5 Rest of LAMEA
7.5.5.5.1 Market size and forecast, by Technology
7.5.5.5.2 Market size and forecast, by Method
7.5.5.5.3 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 VITROCELL Systems GmbH
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Evotec SE
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Biovit
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 MB Research Laboratories
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Emulate, Inc.
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 TARA Biosystems, Inc.
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Bio-Rad Laboratories, Inc.
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Abbott
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Hurel Corporation
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 TissUse GmbH
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
List of Tables
Table 1. Global Measurement and Test Equipment Market, by Type, 2021-2031 ($Million)
Table 2. Measurement and Test Equipment Market Size, for Product, by Region, 2021-2031 ($Million)
Table 3. Measurement and Test Equipment Market for Product, by Country, 2021-2031 ($Million)
Table 4. Global Product Measurement and Test Equipment Market, by Product Type, 2021-2031 ($Million)
Table 5. Measurement and Test Equipment Market, for General Purpose Test Equipment, by Region, 2021-2031 ($Million)
Table 6. Measurement and Test Equipment Market, for General Purpose Test Equipment, by Country, 2021-2031 ($Million)
Table 7. Measurement and Test Equipment Market, for Mechanical Test Equipment, by Region, 2021-2031 ($Million)
Table 8. Measurement and Test Equipment Market, for Mechanical Test Equipment, by Country, 2021-2031 ($Million)
Table 9. Measurement and Test Equipment Market Size, for Services, by Region, 2021-2031 ($Million)
Table 10. Measurement and Test Equipment Market for Services, by Country, 2021-2031 ($Million)
Table 11. Global Services Measurement and Test Equipment Market, by Services Type, 2021-2031 ($Million)
Table 12. Measurement and Test Equipment Market, for Calibration Services, by Region, 2021-2031 ($Million)
Table 13. Measurement and Test Equipment Market, for Calibration Services, by Country, 2021-2031 ($Million)
Table 14. Measurement and Test Equipment Market, for Repair or After Sale Services, by Region, 2021-2031 ($Million)
Table 15. Measurement and Test Equipment Market, for Repair or After Sale Services, by Country, 2021-2031 ($Million)
Table 16. Measurement and Test Equipment Market, for Others, by Region, 2021-2031 ($Million)
Table 17. Measurement and Test Equipment Market, for Others, by Country, 2021-2031 ($Million)
Table 18. Global Measurement and Test Equipment Market, by Application, 2021-2031 ($Million)
Table 19. Measurement and Test Equipment Market Size, for Automotive, by Region, 2021-2031 ($Million)
Table 20. Measurement and Test Equipment Market for Automotive, by Country, 2021-2031 ($Million)
Table 21. Measurement and Test Equipment Market Size, for Aerospace and Defense, by Region, 2021-2031 ($Million)
Table 22. Measurement and Test Equipment Market for Aerospace and Defense, by Country, 2021-2031 ($Million)
Table 23. Measurement and Test Equipment Market Size, for It and Telecommunication, by Region, 2021-2031 ($Million)
Table 24. Measurement and Test Equipment Market for It and Telecommunication, by Country, 2021-2031 ($Million)
Table 25. Measurement and Test Equipment Market Size, for Industrial, by Region, 2021-2031 ($Million)
Table 26. Measurement and Test Equipment Market for Industrial, by Country, 2021-2031 ($Million)
Table 27. Measurement and Test Equipment Market Size, for Healthcare, by Region, 2021-2031 ($Million)
Table 28. Measurement and Test Equipment Market for Healthcare, by Country, 2021-2031 ($Million)
Table 29. Measurement and Test Equipment Market Size, for Semiconductor and Electronics, by Region, 2021-2031 ($Million)
Table 30. Measurement and Test Equipment Market for Semiconductor and Electronics, by Country, 2021-2031 ($Million)
Table 31. Measurement and Test Equipment Market Size, for Education and Government, by Region, 2021-2031 ($Million)
Table 32. Measurement and Test Equipment Market for Education and Government, by Country, 2021-2031 ($Million)
Table 33. Measurement and Test Equipment Market Size, for Manufacturing, by Region, 2021-2031 ($Million)
Table 34. Measurement and Test Equipment Market for Manufacturing, by Country, 2021-2031 ($Million)
Table 35. Measurement and Test Equipment Market Size, for Others, by Region, 2021-2031 ($Million)
Table 36. Measurement and Test Equipment Market for Others, by Country, 2021-2031 ($Million)
Table 37. Measurement and Test Equipment Market, by Region, 2021-2031 ($Million)
Table 38. North America Measurement and Test Equipment Market, by Type, 2021-2031 ($Million)
Table 39. North America Product Measurement and Test Equipment Market, by Product Type, 2021-2031 ($Million)
Table 40. North America Services Measurement and Test Equipment Market, by Services Type, 2021-2031 ($Million)
Table 41. North America Measurement and Test Equipment Market, by Application, 2021-2031 ($Million)
Table 42. North America Measurement and Test Equipment Market, by Country, 2021-2031 ($Million)
Table 43. U.S. Measurement and Test Equipment Market, by Type, 2021-2031 ($Million)
Table 44. U.S. Product Measurement and Test Equipment Market, by Product Type, 2021-2031 ($Million)
Table 45. U.S. Services Measurement and Test Equipment Market, by Services Type, 2021-2031 ($Million)
Table 46. U.S. Measurement and Test Equipment Market, by Application, 2021-2031 ($Million)
Table 47. Canada Measurement and Test Equipment Market, by Type, 2021-2031 ($Million)
Table 48. Canada Product Measurement and Test Equipment Market, by Product Type, 2021-2031 ($Million)
Table 49. Canada Services Measurement and Test Equipment Market, by Services Type, 2021-2031 ($Million)
Table 50. Canada Measurement and Test Equipment Market, by Application, 2021-2031 ($Million)
Table 51. Mexico Measurement and Test Equipment Market, by Type, 2021-2031 ($Million)
Table 52. Mexico Product Measurement and Test Equipment Market, by Product Type, 2021-2031 ($Million)
Table 53. Mexico Services Measurement and Test Equipment Market, by Services Type, 2021-2031 ($Million)
Table 54. Mexico Measurement and Test Equipment Market, by Application, 2021-2031 ($Million)
Table 55. Europe Measurement and Test Equipment Market, by Type, 2021-2031 ($Million)
Table 56. Europe Product Measurement and Test Equipment Market, by Product Type, 2021-2031 ($Million)
Table 57. Europe Services Measurement and Test Equipment Market, by Services Type, 2021-2031 ($Million)
Table 58. Europe Measurement and Test Equipment Market, by Application, 2021-2031 ($Million)
Table 59. Europe Measurement and Test Equipment Market, by Country, 2021-2031 ($Million)
Table 60. United Kingdom Measurement and Test Equipment Market, by Type, 2021-2031 ($Million)
Table 61. United Kingdom Product Measurement and Test Equipment Market, by Product Type, 2021-2031 ($Million)
Table 62. United Kingdom Services Measurement and Test Equipment Market, by Services Type, 2021-2031 ($Million)
Table 63. United Kingdom Measurement and Test Equipment Market, by Application, 2021-2031 ($Million)
Table 64. Germany Measurement and Test Equipment Market, by Type, 2021-2031 ($Million)
Table 65. Germany Product Measurement and Test Equipment Market, by Product Type, 2021-2031 ($Million)
Table 66. Germany Services Measurement and Test Equipment Market, by Services Type, 2021-2031 ($Million)
Table 67. Germany Measurement and Test Equipment Market, by Application, 2021-2031 ($Million)
Table 68. France Measurement and Test Equipment Market, by Type, 2021-2031 ($Million)
Table 69. France Product Measurement and Test Equipment Market, by Product Type, 2021-2031 ($Million)
Table 70. France Services Measurement and Test Equipment Market, by Services Type, 2021-2031 ($Million)
Table 71. France Measurement and Test Equipment Market, by Application, 2021-2031 ($Million)
Table 72. Italy Measurement and Test Equipment Market, by Type, 2021-2031 ($Million)
Table 73. Italy Product Measurement and Test Equipment Market, by Product Type, 2021-2031 ($Million)
Table 74. Italy Services Measurement and Test Equipment Market, by Services Type, 2021-2031 ($Million)
Table 75. Italy Measurement and Test Equipment Market, by Application, 2021-2031 ($Million)
Table 76. Spain Measurement and Test Equipment Market, by Type, 2021-2031 ($Million)
Table 77. Spain Product Measurement and Test Equipment Market, by Product Type, 2021-2031 ($Million)
Table 78. Spain Services Measurement and Test Equipment Market, by Services Type, 2021-2031 ($Million)
Table 79. Spain Measurement and Test Equipment Market, by Application, 2021-2031 ($Million)
Table 80. Russia Measurement and Test Equipment Market, by Type, 2021-2031 ($Million)
Table 81. Russia Product Measurement and Test Equipment Market, by Product Type, 2021-2031 ($Million)
Table 82. Russia Services Measurement and Test Equipment Market, by Services Type, 2021-2031 ($Million)
Table 83. Russia Measurement and Test Equipment Market, by Application, 2021-2031 ($Million)
Table 84. Poland Measurement and Test Equipment Market, by Type, 2021-2031 ($Million)
Table 85. Poland Product Measurement and Test Equipment Market, by Product Type, 2021-2031 ($Million)
Table 86. Poland Services Measurement and Test Equipment Market, by Services Type, 2021-2031 ($Million)
Table 87. Poland Measurement and Test Equipment Market, by Application, 2021-2031 ($Million)
Table 88. Rest of Europe Measurement and Test Equipment Market, by Type, 2021-2031 ($Million)
Table 89. Rest of Europe Product Measurement and Test Equipment Market, by Product Type, 2021-2031 ($Million)
Table 90. Rest of Europe Services Measurement and Test Equipment Market, by Services Type, 2021-2031 ($Million)
Table 91. Rest of Europe Measurement and Test Equipment Market, by Application, 2021-2031 ($Million)
Table 92. Asia-Pacific Measurement and Test Equipment Market, by Type, 2021-2031 ($Million)
Table 93. Asia-Pacific Product Measurement and Test Equipment Market, by Product Type, 2021-2031 ($Million)
Table 94. Asia-Pacific Services Measurement and Test Equipment Market, by Services Type, 2021-2031 ($Million)
Table 95. Asia-Pacific Measurement and Test Equipment Market, by Application, 2021-2031 ($Million)
Table 96. Asia-Pacific Measurement and Test Equipment Market, by Country, 2021-2031 ($Million)
Table 97. China Measurement and Test Equipment Market, by Type, 2021-2031 ($Million)
Table 98. China Product Measurement and Test Equipment Market, by Product Type, 2021-2031 ($Million)
Table 99. China Services Measurement and Test Equipment Market, by Services Type, 2021-2031 ($Million)
Table 100. China Measurement and Test Equipment Market, by Application, 2021-2031 ($Million)
Table 101. Japan Measurement and Test Equipment Market, by Type, 2021-2031 ($Million)
Table 102. Japan Product Measurement and Test Equipment Market, by Product Type, 2021-2031 ($Million)
Table 103. Japan Services Measurement and Test Equipment Market, by Services Type, 2021-2031 ($Million)
Table 104. Japan Measurement and Test Equipment Market, by Application, 2021-2031 ($Million)
Table 105. India Measurement and Test Equipment Market, by Type, 2021-2031 ($Million)
Table 106. India Product Measurement and Test Equipment Market, by Product Type, 2021-2031 ($Million)
Table 107. India Services Measurement and Test Equipment Market, by Services Type, 2021-2031 ($Million)
Table 108. India Measurement and Test Equipment Market, by Application, 2021-2031 ($Million)
Table 109. South Korea Measurement and Test Equipment Market, by Type, 2021-2031 ($Million)
Table 110. South Korea Product Measurement and Test Equipment Market, by Product Type, 2021-2031 ($Million)
Table 111. South Korea Services Measurement and Test Equipment Market, by Services Type, 2021-2031 ($Million)
Table 112. South Korea Measurement and Test Equipment Market, by Application, 2021-2031 ($Million)
Table 113. Singapore Measurement and Test Equipment Market, by Type, 2021-2031 ($Million)
Table 114. Singapore Product Measurement and Test Equipment Market, by Product Type, 2021-2031 ($Million)
Table 115. Singapore Services Measurement and Test Equipment Market, by Services Type, 2021-2031 ($Million)
Table 116. Singapore Measurement and Test Equipment Market, by Application, 2021-2031 ($Million)
Table 117. Australia Measurement and Test Equipment Market, by Type, 2021-2031 ($Million)
Table 118. Australia Product Measurement and Test Equipment Market, by Product Type, 2021-2031 ($Million)
Table 119. Australia Services Measurement and Test Equipment Market, by Services Type, 2021-2031 ($Million)
Table 120. Australia Measurement and Test Equipment Market, by Application, 2021-2031 ($Million)
Table 121. Indonesia Measurement and Test Equipment Market, by Type, 2021-2031 ($Million)
Table 122. Indonesia Product Measurement and Test Equipment Market, by Product Type, 2021-2031 ($Million)
Table 123. Indonesia Services Measurement and Test Equipment Market, by Services Type, 2021-2031 ($Million)
Table 124. Indonesia Measurement and Test Equipment Market, by Application, 2021-2031 ($Million)
Table 125. Rest of Asia-Pacific Measurement and Test Equipment Market, by Type, 2021-2031 ($Million)
Table 126. Rest of Asia-Pacific Product Measurement and Test Equipment Market, by Product Type, 2021-2031 ($Million)
Table 127. Rest of Asia-Pacific Services Measurement and Test Equipment Market, by Services Type, 2021-2031 ($Million)
Table 128. Rest of Asia-Pacific Measurement and Test Equipment Market, by Application, 2021-2031 ($Million)
Table 129. LAMEA Measurement and Test Equipment Market, by Type, 2021-2031 ($Million)
Table 130. LAMEA Product Measurement and Test Equipment Market, by Product Type, 2021-2031 ($Million)
Table 131. LAMEA Services Measurement and Test Equipment Market, by Services Type, 2021-2031 ($Million)
Table 132. LAMEA Measurement and Test Equipment Market, by Application, 2021-2031 ($Million)
Table 133. LAMEA Measurement and Test Equipment Market, by Country, 2021-2031 ($Million)
Table 134. Latin America Measurement and Test Equipment Market, by Type, 2021-2031 ($Million)
Table 135. Latin America Product Measurement and Test Equipment Market, by Product Type, 2021-2031 ($Million)
Table 136. Latin America Services Measurement and Test Equipment Market, by Services Type, 2021-2031 ($Million)
Table 137. Latin America Measurement and Test Equipment Market, by Application, 2021-2031 ($Million)
Table 138. Middle East Measurement and Test Equipment Market, by Type, 2021-2031 ($Million)
Table 139. Middle East Product Measurement and Test Equipment Market, by Product Type, 2021-2031 ($Million)
Table 140. Middle East Services Measurement and Test Equipment Market, by Services Type, 2021-2031 ($Million)
Table 141. Middle East Measurement and Test Equipment Market, by Application, 2021-2031 ($Million)
Table 142. Africa Measurement and Test Equipment Market, by Type, 2021-2031 ($Million)
Table 143. Africa Product Measurement and Test Equipment Market, by Product Type, 2021-2031 ($Million)
Table 144. Africa Services Measurement and Test Equipment Market, by Services Type, 2021-2031 ($Million)
Table 145. Africa Measurement and Test Equipment Market, by Application, 2021-2031 ($Million)
Table 146. Anritsu Corporation: Company Snapshot
Table 147. Anritsu Corporation: Operating Segments
Table 148. Anritsu Corporation: Product Portfolio
Table 149. Anritsu Corporation: Net Sales
Table 150. Anritsu Corporation: Key Stratergies
Table 151. Fortive Corporation: Company Snapshot
Table 152. Fortive Corporation: Operating Segments
Table 153. Fortive Corporation: Product Portfolio
Table 154. Fortive Corporation: Net Sales
Table 155. Fortive Corporation: Key Stratergies
Table 156. Good Will Instrument Co. Ltd.: Company Snapshot
Table 157. Good Will Instrument Co. Ltd.: Operating Segments
Table 158. Good Will Instrument Co. Ltd.: Product Portfolio
Table 159. Good Will Instrument Co. Ltd.: Net Sales
Table 160. Good Will Instrument Co. Ltd.: Key Stratergies
Table 161. Keysight Technologies, Inc.: Company Snapshot
Table 162. Keysight Technologies, Inc.: Operating Segments
Table 163. Keysight Technologies, Inc.: Product Portfolio
Table 164. Keysight Technologies, Inc.: Net Sales
Table 165. Keysight Technologies, Inc.: Key Stratergies
Table 166. Owon Technology: Company Snapshot
Table 167. Owon Technology: Operating Segments
Table 168. Owon Technology: Product Portfolio
Table 169. Owon Technology: Net Sales
Table 170. Owon Technology: Key Stratergies
Table 171. Qingdao Hantek Electronic Co., Ltd.: Company Snapshot
Table 172. Qingdao Hantek Electronic Co., Ltd.: Operating Segments
Table 173. Qingdao Hantek Electronic Co., Ltd.: Product Portfolio
Table 174. Qingdao Hantek Electronic Co., Ltd.: Net Sales
Table 175. Qingdao Hantek Electronic Co., Ltd.: Key Stratergies
Table 176. National Instruments Corporation: Company Snapshot
Table 177. National Instruments Corporation: Operating Segments
Table 178. National Instruments Corporation: Product Portfolio
Table 179. National Instruments Corporation: Net Sales
Table 180. National Instruments Corporation: Key Stratergies
Table 181. Rigol Technologies Co., Ltd.: Company Snapshot
Table 182. Rigol Technologies Co., Ltd.: Operating Segments
Table 183. Rigol Technologies Co., Ltd.: Product Portfolio
Table 184. Rigol Technologies Co., Ltd.: Net Sales
Table 185. Rigol Technologies Co., Ltd.: Key Stratergies
Table 186. Rohde & Schwarz GmbH & Co. Kg: Company Snapshot
Table 187. Rohde & Schwarz GmbH & Co. Kg: Operating Segments
Table 188. Rohde & Schwarz GmbH & Co. Kg: Product Portfolio
Table 189. Rohde & Schwarz GmbH & Co. Kg: Net Sales
Table 190. Rohde & Schwarz GmbH & Co. Kg: Key Stratergies
Table 191. Uni-Trend Technology: Company Snapshot
Table 192. Uni-Trend Technology: Operating Segments
Table 193. Uni-Trend Technology: Product Portfolio
Table 194. Uni-Trend Technology: Net Sales
Table 195. Uni-Trend Technology: Key Stratergies
Table 196. Yokogawa Electric Corporation: Company Snapshot
Table 197. Yokogawa Electric Corporation: Operating Segments
Table 198. Yokogawa Electric Corporation: Product Portfolio
Table 199. Yokogawa Electric Corporation: Net Sales
Table 200. Yokogawa Electric Corporation: Key Stratergies
Table 201. Eurofins E&E: Company Snapshot
Table 202. Eurofins E&E: Operating Segments
Table 203. Eurofins E&E: Product Portfolio
Table 204. Eurofins E&E: Net Sales
Table 205. Eurofins E&E: Key Stratergies
Table 206. Nts: Company Snapshot
Table 207. Nts: Operating Segments
Table 208. Nts: Product Portfolio
Table 209. Nts: Net Sales
Table 210. Nts: Key Stratergies
Table 211. Hqts Group Ltd.: Company Snapshot
Table 212. Hqts Group Ltd.: Operating Segments
Table 213. Hqts Group Ltd.: Product Portfolio
Table 214. Hqts Group Ltd.: Net Sales
Table 215. Hqts Group Ltd.: Key Stratergies
Table 216. Ama Laboratories: Company Snapshot
Table 217. Ama Laboratories: Operating Segments
Table 218. Ama Laboratories: Product Portfolio
Table 219. Ama Laboratories: Net Sales
Table 220. Ama Laboratories: Key Stratergies
Table 221. Applied Technical Services, LLC (Ats): Company Snapshot
Table 222. Applied Technical Services, LLC (Ats): Operating Segments
Table 223. Applied Technical Services, LLC (Ats): Product Portfolio
Table 224. Applied Technical Services, LLC (Ats): Net Sales
Table 225. Applied Technical Services, LLC (Ats): Key Stratergies
Table 226. Nsl Analytical Services, Inc.: Company Snapshot
Table 227. Nsl Analytical Services, Inc.: Operating Segments
Table 228. Nsl Analytical Services, Inc.: Product Portfolio
Table 229. Nsl Analytical Services, Inc.: Net Sales
Table 230. Nsl Analytical Services, Inc.: Key Stratergies
List of Figures
Figure 1. Non-Animal Alternative Testing Market Segmentation
Figure 2. Non-Animal Alternative Testing Market,2021-2030
Figure 3. Non-Animal Alternative Testing Market,2021-2030
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Non-Animal Alternative Testing Market:Drivers, Restraints and Opportunities
Figure 12. Regulatory Guidelines
Figure 13. Value Chain Analysis
Figure 14. Market Share Analysis
Figure 15. Key Regulation Analysis
Figure 16. Patent Analysis by Company
Figure 17. Patent Analysis by Country
Figure 18. Non-Animal Alternative Testing Market,By Technology,2021(%)
Figure 19. Comparative Share Analysis of Cell Culture Non-Animal Alternative Testing Market,2021-2030(%)
Figure 20. Comparative Share Analysis of High Throughput Non-Animal Alternative Testing Market,2021-2030(%)
Figure 21. Comparative Share Analysis of Molecular Imaging Non-Animal Alternative Testing Market,2021-2030(%)
Figure 22. Comparative Share Analysis of Omic Technology Non-Animal Alternative Testing Market,2021-2030(%)
Figure 23. Non-Animal Alternative Testing Market,By Method,2021(%)
Figure 24. Comparative Share Analysis of Cellular Assay Non-Animal Alternative Testing Market,2021-2030(%)
Figure 25. Comparative Share Analysis of Biochemical Assay Non-Animal Alternative Testing Market,2021-2030(%)
Figure 26. Comparative Share Analysis of In-Silico Non-Animal Alternative Testing Market,2021-2030(%)
Figure 27. Comparative Share Analysis of Ex-Vivo Non-Animal Alternative Testing Market,2021-2030(%)
Figure 28. Non-Animal Alternative Testing Market,By End-user,2021(%)
Figure 29. Comparative Share Analysis of Pharmaceutical Industry Non-Animal Alternative Testing Market,2021-2030(%)
Figure 30. Comparative Share Analysis of Cosmetics & Household Products Non-Animal Alternative Testing Market,2021-2030(%)
Figure 31. Comparative Share Analysis of Diagnostics Non-Animal Alternative Testing Market,2021-2030(%)
Figure 32. Comparative Share Analysis of Chemicals Industry Non-Animal Alternative Testing Market,2021-2030(%)
Figure 33. Comparative Share Analysis of Food Industry Non-Animal Alternative Testing Market,2021-2030(%)
Figure 34. Non-Animal Alternative Testing Market by Region,2021
Figure 35. U.S. Non-Animal Alternative Testing Market,2021-2030($Million)
Figure 36. Canada Non-Animal Alternative Testing Market,2021-2030($Million)
Figure 37. Mexico Non-Animal Alternative Testing Market,2021-2030($Million)
Figure 38. Germany Non-Animal Alternative Testing Market,2021-2030($Million)
Figure 39. United Kingdom Non-Animal Alternative Testing Market,2021-2030($Million)
Figure 40. France Non-Animal Alternative Testing Market,2021-2030($Million)
Figure 41. Spain Non-Animal Alternative Testing Market,2021-2030($Million)
Figure 42. Italy Non-Animal Alternative Testing Market,2021-2030($Million)
Figure 43. Rest of Europe Non-Animal Alternative Testing Market,2021-2030($Million)
Figure 44. China Non-Animal Alternative Testing Market,2021-2030($Million)
Figure 45. Japan Non-Animal Alternative Testing Market,2021-2030($Million)
Figure 46. India Non-Animal Alternative Testing Market,2021-2030($Million)
Figure 47. South Korea Non-Animal Alternative Testing Market,2021-2030($Million)
Figure 48. Australia Non-Animal Alternative Testing Market,2021-2030($Million)
Figure 49. Rest of Asia-Pacific Non-Animal Alternative Testing Market,2021-2030($Million)
Figure 50. Brazil Non-Animal Alternative Testing Market,2021-2030($Million)
Figure 51. Saudi Arabia Non-Animal Alternative Testing Market,2021-2030($Million)
Figure 52. Uae Non-Animal Alternative Testing Market,2021-2030($Million)
Figure 53. South Africa Non-Animal Alternative Testing Market,2021-2030($Million)
Figure 54. Rest of LAMEA Non-Animal Alternative Testing Market,2021-2030($Million)
Figure 55. Top Winning Strategies, by Year
Figure 56. Top Winning Strategies, by Development
Figure 57. Top Winning Strategies, by Company
Figure 58. Product Mapping of Top 10 Players
Figure 59. Competitive Dashboard
Figure 60. Competitive Heatmap of Top 10 Key Players
Figure 61. Vitrocell Systems GmbH.: Net Sales ,($Million)
Figure 62. Evotec SE.: Net Sales ,($Million)
Figure 63. Biovit.: Net Sales ,($Million)
Figure 64. Mb Research Laboratories.: Net Sales ,($Million)
Figure 65. Emulate, Inc..: Net Sales ,($Million)
Figure 66. Tara Biosystems, Inc..: Net Sales ,($Million)
Figure 67. Bio-Rad Laboratories, Inc..: Net Sales ,($Million)
Figure 68. Abbott.: Net Sales ,($Million)
Figure 69. Hurel Corporation.: Net Sales ,($Million)
Figure 70. Tissuse GmbH.: Net Sales ,($Million)

Executive Summary

According to the report, titled, “Non-Animal Alternative Testing Market," the non-animal alternative testing market size was $9.8 billion in 2021, and is estimated to reach $29.4 billion by 2030, growing at a CAGR of 13.5% from 2022 to 2030.

The most recent methods, known as non-animal alternatives, are frequently utilized in scientific research projects for a variety of purposes, including chemical testing, medicine development, and cosmetic product testing. The use of non-animal alternatives testing involves a wide range of technologies, including cell culture, high throughput, and omic.

In the anticipated time frame, the market share rise of non-animal alternative testing is anticipated to be driven by the rapidly rising cases of chronic diseases including viral diseases among millennial as a result of factors such as bad food eating habits. Worldwide, a great number of people struggle with various illnesses such as high blood pressure. Several times, the virus develops a particular drug resistance, making it impossible to treat the patient's illness with any medication. This has significantly raised the market demand for new medications. Future market growth for non-animal alternative testing is projected to be boosted by this factor. Additionally, several nations forbid using animals in the pre-clinical testing of a variety of pharmaceuticals and cosmetics. In addition, evolving ethical concern related to the use of animals in product testing are anticipated to speed up the market expansion.

Non-animal alternative testing is a new and developing technology, and few scientists are familiar with how it should be used. The market share expansion of non-animal alternative testing is therefore expected to be constrained by this factor in the future.

Future market share growth for non-animal alternative testing is anticipated to be fueled by improvements in the currently available non-animal alternative testing products and also with the introduction of new products in market. In order to address the rising needs for cutting-edge drug testing solutions for various ailments such as diabetes, major industry players in the non-animal alternative testing market have started concentrating on creating and releasing new products such as artificial organs. These elements are projected to fuel the expansion of the non-animal alternative testing market in the coming years.

The global non-animal alternative testing market share is segmented based on technology, method, end-user, and region. By technology, it is classified into cell culture technology, high throughput technology, molecular imaging, and omic technology. By method, it is classified into cellular assay, biochemical assay, in silico, and ex-vivo. By end-user, it is classified into pharmaceutical industry, cosmetics & household products, diagnostics, chemical industry, and food industry. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players profiled in the non-animal alternative testing industry report include VITROCELL Systems GmbH, Evotec SE, Biovit, MB Research Laboratories, Emulate, Inc., TARA Biosystems, Inc., Bio-Rad Laboratories, Inc., Abbott, Hurel Corporation, and TissUse GmbH.

The report offers a comprehensive analysis of the global non-animal alternative testing market trends by thoroughly studying different aspects of the market including major segments, market statistics, market dynamics, regional market outlook, investment opportunities, and top players working towards growth of the market. The report also sheds light on the present scenario and upcoming trends & developments that are contributing to growth of the market. Moreover, restraints and challenges that hold power to obstruct the market growth are also profiled in the report along with the Porter’s five forces analysis of the market to elucidate factors such as competitive landscape, bargaining power of buyers and suppliers, threats of new players, and emergence of substitutes in the market. The report provides the global non-animal alternative testing market analysis from 2021 - 2030 and the global non-animal alternative testing market forecast from 2022 - 2030.

Impact of COVID-19 on the Global Non-animal Alternative Testing Industry

  • The COVID-19 pandemic has shown a favorable effect on the expansion of the non-animal alternative testing sector
  • Patients are now being extremely cautious of viral infections and its severe symptoms due to the COVID-19 pandemic which had a very negative influence on peoples' health and welfare worldwide
  • Many researchers have banned themselves from working in a wet laboratory and making any form of contact with either humans or animals during pre-clinical testing of the medications due to the high rate of coronavirus transmission and prevalence of significant symptoms. This has led to a rise in the usage of less invasive testing methods such as microarrays that do not utilize animals.
  • Additionally, with the number of COVID-19 cases increasing globally, there is a greater need for an effective anti-pandemic medicine, which has further prompted researchers and scientists to utilize non-animal alternative testing to expedite their research efforts. This factor has helped the market to thrive during the pandemic time.

Key Findings of the Study

  • Based on technology, the cell culture technology sub-segment emerged as the global leader in 2020 and the omic technology sub-segment is anticipated to be the fastest growing sub-segment during the forecast period
  • Based on method, the cellular assay sub-segment emerged as the global leader in 2020 and the ex-vivo sub-segment is anticipated to be the fastest growing sub-segment during the forecast period
  • Based on end-user, the pharmaceutical industry sub-segment emerged as the global leader in 2020 and the chemical industry sub-segment is predicted to show the fastest growth in the upcoming years
  • Based on region, the North America market registered the highest market share in 2020 and Asia-Pacific market is predicted to show the fastest growth in the upcoming years

Companies Mentioned

  • Vitrocell Systems GmbH
  • Evotec Se
  • Biovit
  • Mb Research Laboratories
  • Emulate, Inc.
  • Tara Biosystems, Inc.
  • Bio-Rad Laboratories, Inc.
  • Abbott
  • Hurel Corporation
  • Tissuse Gmbh

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...